SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001068238-24-000115
Filing Date
2024-05-22
Accepted
2024-05-22 16:33:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 GKCC LLC SCHEDULE 13G gkcc_sch13g.htm SC 13G 33200
  Complete submission text file 0001068238-24-000115.txt   34880
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Subject) CIK: 0001840229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92968 | Film No.: 24973826
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 501 SILVERSIDE ROAD SUITE 87AVA WILMINGTON DE 19809
Business Address 501 SILVERSIDE ROAD SUITE 87AVA WILMINGTON DE 19809 (302) 992-8882
GKCC, LLC (Filed by) CIK: 0001977769 (see all company filings)

IRS No.: 472175589 | State of Incorp.: DE
Type: SC 13G